MVZ DiaMedicum Bad Mergentheim GmbH

The site focuses on evaluating new treatments that aid weight reduction in individuals with overweight or obesity, with or without diabetes.

• CagriSema efficacy in weight loss
• Maridebart cafraglutide outcomes for obesity
• Integration of lifestyle counseling with medication

These studies aim to improve body‑weight control and support healthier lifestyles for patients struggling with excess weight.

Research at MVZ DiaMedicum Bad Mergentheim GmbH includes assessment of novel insulin regimens for both type 1 diabetes and type 2 diabetes.

• Once‑weekly insulin icodec versus daily basal insulin
• Combination therapy with insulin aspart
• Real‑world effectiveness in routine practice

The goal is to simplify therapy while maintaining or improving blood‑sugar control for people living with diabetes.

The clinic investigates combined approaches targeting obesity and diabetes, reflecting the overlap of metabolic disorders.

• Dual outcomes on weight and HbA1c
• Adjunctive diet and exercise programs
• Real‑world effectiveness assessments

By linking weight loss and glucose regulation, the trials seek to offer comprehensive solutions for patients with co‑existing metabolic conditions.